Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.09 0.02
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.078 0.02
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.079 0.02
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.077 0.02
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.08 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.085 0.02
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.089 0.02
Download CSV